Research advances in silybin in treatment of drug-induced liver injury

Drug-induced liver injury is commonly seen in clinical practice and is usually caused by antipsychotic drugs, antitubercular agents, paracetamol, and statins. Silybin, a substance with biological activity in silymarin extract, has antioxidant, anti-inflammatory, and anti-fibrosis effects. This artic...

Full description

Bibliographic Details
Main Authors:	SHAO Shuang, LIU Chunyan, GAO Yanhang
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2017-06-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8346

id	doaj-af5df8b050704554bdb64c8608ce2125
record_format	Article
spelling	doaj-af5df8b050704554bdb64c8608ce21252020-11-25T00:30:05ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562017-06-013361179118210.3969/j.issn.1001-5256.2017.06.035Research advances in silybin in treatment of drug-induced liver injurySHAO Shuang0LIU Chunyan1GAO Yanhang2Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Hepatology, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Hepatology, The First Hospital of Jilin University, Changchun 130021, ChinaDrug-induced liver injury is commonly seen in clinical practice and is usually caused by antipsychotic drugs, antitubercular agents, paracetamol, and statins. Silybin, a substance with biological activity in silymarin extract, has antioxidant, anti-inflammatory, and anti-fibrosis effects. This article summarizes the research advances in silybin in the prevention and treatment of drug-induced liver injury. http://www.lcgdbzz.org/qk_content.asp?id=8346
collection	DOAJ
language	zho
format	Article
sources	DOAJ
author	SHAO Shuang LIU Chunyan GAO Yanhang
spellingShingle	SHAO Shuang LIU Chunyan GAO Yanhang Research advances in silybin in treatment of drug-induced liver injury Linchuang Gandanbing Zazhi
author_facet	SHAO Shuang LIU Chunyan GAO Yanhang
author_sort	SHAO Shuang
title	Research advances in silybin in treatment of drug-induced liver injury
title_short	Research advances in silybin in treatment of drug-induced liver injury
title_full	Research advances in silybin in treatment of drug-induced liver injury
title_fullStr	Research advances in silybin in treatment of drug-induced liver injury
title_full_unstemmed	Research advances in silybin in treatment of drug-induced liver injury
title_sort	research advances in silybin in treatment of drug-induced liver injury
publisher	Editorial Department of Journal of Clinical Hepatology
series	Linchuang Gandanbing Zazhi
issn	1001-5256 1001-5256
publishDate	2017-06-01
description	Drug-induced liver injury is commonly seen in clinical practice and is usually caused by antipsychotic drugs, antitubercular agents, paracetamol, and statins. Silybin, a substance with biological activity in silymarin extract, has antioxidant, anti-inflammatory, and anti-fibrosis effects. This article summarizes the research advances in silybin in the prevention and treatment of drug-induced liver injury.
url	http://www.lcgdbzz.org/qk_content.asp?id=8346
work_keys_str_mv	AT shaoshuang researchadvancesinsilybinintreatmentofdruginducedliverinjury AT liuchunyan researchadvancesinsilybinintreatmentofdruginducedliverinjury AT gaoyanhang researchadvancesinsilybinintreatmentofdruginducedliverinjury
_version_	1725327980579782656

Research advances in silybin in treatment of drug-induced liver injury

Similar Items